Medtronic · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← MDT

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2027 Q1	2026-07-31	9.76	+13.7%	65.0%	1.76	1.47	15.1%	1.29	1.14	0.27	0.92
FY2026 Q4	2026-04-24	9.81	+9.9%	65.4%	1.87	-3.56	-36.3%	2.09	0.96	0.44	0.91
FY2026 Q3	2026-01-23	9.02	+8.7%	63.8%	1.46	1.14	12.7%	2.30	0.89	0.11	0.91
FY2026 Q2	2025-10-24	8.96	+6.6%	65.8%	1.69	1.37	15.3%	0.46	1.07	0.37	0.91
FY2026 Q1	2025-07-25	8.58	+8.4%	65.0%	1.45	1.04	12.1%	0.58	0.81	0.12	0.91
FY2025 Q4	2025-04-25	8.93	+3.9%	64.8%	1.44	-3.61	-40.4%	2.07	0.81	0.27	0.90
FY2025 Q3	2025-01-24	8.29	+2.5%	66.5%	1.65	1.29	15.6%	2.10	1.01	0.18	0.90
FY2025 Q2	2024-10-25	8.40	+5.2%	64.9%	1.60	1.27	15.1%	0.55	0.99	0.29	0.90
FY2025 Q1	2024-07-26	7.92	+2.8%	65.1%	1.28	1.04	13.2%	0.47	0.80	2.49	0.90
FY2024 Q4	2024-04-26	8.59	+0.5%	64.5%	1.05	-3.02	-35.2%	2.35	0.50	1.63	0.91
FY2024 Q3	2024-01-26	8.09	+4.7%	65.6%	1.48	1.32	16.3%	2.13	0.99	0.13	0.92
FY2024 Q2	2023-10-27	7.98	+5.3%	65.4%	1.34	0.91	11.4%	0.20	0.68	0.23	0.92
FY2024 Q1	2023-07-28	7.70	—	65.9%	1.27	0.79	10.3%	0.52	0.59	0.15	0.92
FY2023 Q4	2023-04-28	8.54	—	65.1%	1.56	-2.58	-30.2%	2.08	0.88	0.10	0.91
FY2023 Q3	2023-01-27	7.73	—	65.2%	1.39	1.22	15.8%	1.24	0.92	0.07	0.90
FY2023 Q2	2022-10-28	7.59	—	66.6%	1.40	0.43	5.6%	0.60	0.32	0.14	0.90

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.